SHED-Derived Exosomes Attenuate Alzheimer's Disease Pathology in iPSC-Derived Cerebral Organoid Model
This study demonstrates that SHED-derived exosomes attenuate Alzheimer's disease pathology and functional excitotoxicity in patient-derived 2D and 3D cerebral organoid models by delivering therapeutic miRNAs that modulate tau hyperphosphorylation and amyloid processing, thereby validating their potential as a multi-target biological therapy for dementia.